WICELL RESEARCH INSTITUTE INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

ROBERT DRAPE

Phone

6083164717

Tax Period

2023-07-01 to 2024-06-30

WICELL RESEARCH INSTITUTE INC, founded in 1999, is a community nonprofit in the Medical Research sector that reported $8.4M in total revenue in fiscal year 2023. Expenses of $8.1M left a modest 4% surplus.

Mission

SEE PART I, LINE 1

Program Service Accomplishments

Program 1

Expenses: $2,807,618 Revenue: $3,832,445

CHARACTERIZATION SERVICES WICELL ESTABLISHED A CHARACTERIZATION SERVICES PROGRAM IN 2005 TO ENSURE HIGH-QUALITY PSC LINES DISTRIBUTED BY THE WICELL STEM CELL BANK AND TO SERVE THE RESEARCH COMMUNITY IN THE ESSENTIAL ONGOING CHARACTERIZATION OF CELL LINES USED IN THEIR RESEARCH. WICELL OFFERS ITS CHARACTERIZATION SERVICES TO HELP IMPROVE THE RIGOR AND REPRODUCIBILITY OF ALL RESEARCH UTILIZING CELL LINES TO ACADEMIC AND COMMERCIAL LABS IN THE US AND WORLDWIDE.

Program 2

Expenses: $1,559,168 Revenue: $4,023,092

WICELL STEM CELL BANK WICELL'S STEM CELL BANK REPOSITORY ACCEPTS DEPOSITS FROM OTHER ACADEMIC INSTITUTIONS ENSURING THESE PLURIPOTENT STEM CELL (PSC) LINES ARE AVAILABLE TO THE RESEARCH COMMUNITY IN PERPETUITY. WICELL BANKS, CHARACTERIZES, AND DISTRIBUTES THESE HIGH-QUALITY PSC LINES TO ACADEMIC AND COMMERCIAL RESEARCH LABORATORIES TO SUPPORT BASIC AND TRANSLATIONAL RESEARCH IN STEM CELL SCIENCE, REGENERATIVE MEDICINE, AND APPLICATIONS TO IMPROVE HUMAN HEALTH. DURING FISCAL YEAR 2024, WICELL DISTRIBUTED 705 PSC LINES, BRINGING TOTAL DISTRIBUTIONS TO 11,524.

Program 3

Expenses: $277,629 Revenue: $478,864

CORE SERVICES WICELL DEVELOPED THE CORE SERVICE PROGRAM IN 2009 TO MEET THE NEEDS OF THE UW STEM CELL RESEARCHERS IN MAKING SURE THAT THEY RECEIVE QUALIFIED SUPPLIES ESSENTIAL FOR PSC CULTURE. WICELL PURCHASES BULK LOTS OF SUPPLIES (MEDIA, REAGENTS, ETC.), QUALIFIES THEM TO ENSURE THEY SUPPORT STEM CELL CULTURE, AND DELIVERS THE QUALIFIED SUPPLIES TO CAMPUS RESEARCHERS WEEKLY. THIS SAVES THE RESEARCHERS TIME, MONEY, STORAGE SPACE, AND ENSURES QUALITY MATERIALS ARE AVAILABLE, ALLOWING THEM TO FOCUS MORE ON THEIR RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $8,334,401

Investment Income $30,951

Other Revenue $50,958

TOTAL REVENUE $8,416,310

Expense Breakdown

Grants Paid $0

Salaries & Benefits $4,310,742

Fundraising Expenses $0

Program Expenses $5,000,168

Other Expenses $3,776,926

TOTAL EXPENSES $8,087,668

Year-over-Year Comparison

	2023	2022	Change
Revenue	$8,416,310	$7,838,212	+0.1%
Expenses	$8,087,668	$6,979,901	+0.2%
Net Income	$328,642	$858,311	-0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$593,880

Total Directors

$383,092

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ROBERT DRAPE	CHIEF EXECUTIVE OFFICER	40.00	Officer Director	$316,320	$62,272	$378,592
ANITA BHATTACHARYYA	DIRECTOR	1.00	Director	$1,000	$0	$1,000
DEREK HEI	DIRECTOR/CHAIR	1.00	Officer Director	$1,000	$0	$1,000
JEANINE BURMANIA	DIRECTOR	1.00	Director	$500	$0	$500
CYNTHIA CZAJKOWSKI	DIRECTOR	1.00	Director	$500	$0	$500
MICHAEL FALK	DIRECTOR	1.00	Director	$500	$0	$500
JON LEVINE	DIRECTOR (UNTIL 6/21/24)	1.00	Director	$500	$0	$500
DEBORAH KELLER	DIRECTOR/CHAIR (UNTIL 3/8/24)	3.00	Officer Director	$500	$0	$500
SETH TAAPKEN	DIRECTOR OF OPERATIONS	40.00	Officer	$164,119	$49,669	$213,788
TENNEILLE LUDWIG	SNR SCIENTIST/DIR. WICELL STEM CELL BANK	40.00	Highest	$199,953	$30,983	$230,936
JENNA GAY	DIRECTOR, QUALITY ASSURANCE	40.00	Highest	$115,247	$39,544	$154,791
JAMES JOHNSON	SCIENTIST	40.00	Highest	$107,842	$17,949	$125,791

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$8,416,310	$8,087,668	$6,715,538	$328,642
2023	$7,838,212	$6,979,901	$6,085,759	$858,311
2022	$7,939,160	$5,990,252	$4,969,313	$1,948,908
2021	$5,922,668	$5,311,660	$3,438,237	$611,008
2020	$4,540,573	$5,013,253	$2,605,114	$-472,680
2019	$4,468,797	$5,243,210	$2,457,986	$-774,413